Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
J&J changes New York state of mind, closing JLABS site
The pharma is transitioning operations and management of its New York City JLABS space to the site owner, the New York Genome Center (NYGC)
Will Maddox
Mar 17, 2026 11:20am
Bicycle pumps brakes on lead program, deflates headcount by 30%
Mar 17, 2026 11:14am
Stop asking for an AI strategy: 3 questions clinical leaders should ask instead
Brought to you by
Syneos Health
Pfizer's hotly tipped breast cancer prospect records phase 2 win
Mar 17, 2026 8:40am
How physiology powers biotech innovation
Brought to you by
American Physiological Society
Altai Capital angles for OraSure board seats and a sale
Mar 17, 2026 12:40pm
More News
FDA rejects Aldeyra eye disease candidate for 3rd time
Mar 17, 2026 11:12am
Alcon, Lensar drop $356M deal after black eye from FTC
Mar 17, 2026 11:00am
Fierce Biotech Fundraising Tracker '26: Prolium, Atrium & more
Mar 17, 2026 10:00am
Fierce Biotech Layoff Tracker 2026: Bicycle, Inovio & more
Mar 17, 2026 8:30am
See more stories